GenomeNet

Database: PDB
Entry: 3GAV
LinkDB: 3GAV
Original site: 3GAV 
HEADER    IMMUNE SYSTEM                           18-FEB-09   3GAV              
TITLE     SOLUTION STRUCTURE OF HUMAN COMPLEMENT FACTOR H IN 137 MM NACL BUFFER 
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: COMPLEMENT FACTOR H;                                       
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: H FACTOR 1                                                  
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 OTHER_DETAILS: PURIFIED FROM POOLED PLASMA                           
KEYWDS    X-RAY SOLUTION SCATTERING, COMPLEMENT FACTOR H, SCR DOMAIN, AGE-      
KEYWDS   2 RELATED MACULAR DEGENERATION, COMPLEMENT ALTERNATE PATHWAY, DISEASE  
KEYWDS   3 MUTATION, GLYCOPROTEIN, IMMUNE RESPONSE, INNATE IMMUNITY, SECRETED,  
KEYWDS   4 SUSHI, IMMUNE SYSTEM                                                 
EXPDTA    SOLUTION SCATTERING                                                   
NUMMDL    8                                                                     
MDLTYP    CA ATOMS ONLY, CHAIN A                                                
AUTHOR    A.I.OKEMEFUNA,R.NAN,J.GOR,S.J.PERKINS                                 
REVDAT   8   21-FEB-24 3GAV    1       SEQADV                                   
REVDAT   7   01-NOV-17 3GAV    1       REMARK                                   
REVDAT   6   27-JUL-11 3GAV    1       REVDAT                                   
REVDAT   5   13-JUL-11 3GAV    1       VERSN                                    
REVDAT   4   07-APR-10 3GAV    1       REMARK                                   
REVDAT   3   11-AUG-09 3GAV    1       JRNL                                     
REVDAT   2   16-JUN-09 3GAV    1       CRYST1                                   
REVDAT   1   09-JUN-09 3GAV    0                                                
JRNL        AUTH   A.I.OKEMEFUNA,R.NAN,J.GOR,S.J.PERKINS                        
JRNL        TITL   ELECTROSTATIC INTERACTIONS CONTRIBUTE TO THE FOLDED-BACK     
JRNL        TITL 2 CONFORMATION OF WILD TYPE HUMAN FACTOR H.                    
JRNL        REF    J.MOL.BIOL.                   V. 391    98 2009              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   19505476                                                     
JRNL        DOI    10.1016/J.JMB.2009.06.010                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : INSIGHT II 98                                        
REMARK   3   AUTHORS     :                                                      
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 1213                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 0                                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: THE COORDINATES CONTAIN ONLY CA ATOMS.    
REMARK   4                                                                      
REMARK   4 3GAV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-09.                  
REMARK 100 THE DEPOSITION ID IS D_1000051637.                                   
REMARK 265                                                                      
REMARK 265 EXPERIMENTAL DETAILS                                                 
REMARK 265                                                                      
REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING                       
REMARK 265  DATA ACQUISITION                                                    
REMARK 265   RADIATION/NEUTRON SOURCE                 : ESRF GRENOBLE           
REMARK 265   SYNCHROTRON (Y/N)                        : Y                       
REMARK 265   BEAMLINE TYPE                            : IDO2                    
REMARK 265   BEAMLINE INSTRUMENT                      : NULL                    
REMARK 265   DETECTOR TYPE                            : FRELON CCD CAMERA       
REMARK 265   DETECTOR MANUFACTURER DETAILS            : NULL                    
REMARK 265   TEMPERATURE (KELVIN)                     : 293                     
REMARK 265   PH                                       : 7.4                     
REMARK 265   NUMBER OF TIME FRAMES USED               : 10                      
REMARK 265   PROTEIN CONCENTRATION RANGE (MG/ML)      : 0.40                    
REMARK 265   SAMPLE BUFFER                            : 137 MM NACL 10 MM       
REMARK 265                                              HEPES 0.5 MM EDTA       
REMARK 265   DATA REDUCTION SOFTWARE                  : MULTICCD                
REMARK 265   GUINIER MEAN RADIUS OF GYRATION (NM)     : 8.90                    
REMARK 265   SIGMA MEAN RADIUS OF GYRATION            : 0.19                    
REMARK 265   R(XS-1) MEAN CROSS SECTIONAL RADII (NM)  : 2.51                    
REMARK 265   R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.06                    
REMARK 265   R(XS-2) MEAN CROSS SECTIONAL RADII (NM)  : 1.79                    
REMARK 265   R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.01                    
REMARK 265   P(R) PROTEIN LENGTH (NM)                 : 1                       
REMARK 265                                                                      
REMARK 265 DATA ANALYSIS AND MODEL FITTING:                                     
REMARK 265  METHOD USED TO DETERMINE THE STRUCTURE: NULL                        
REMARK 265  SOFTWARE USED    : INSIGHT II, SCTPL7, GNOM                         
REMARK 265  SOFTWARE AUTHORS : NULL                                             
REMARK 265  STARTING MODEL   : NULL                                             
REMARK 265                                                                      
REMARK 265 CONFORMERS, NUMBER CALCULATED   : 5000                               
REMARK 265 CONFORMERS, NUMBER SUBMITTED    : 8                                  
REMARK 265 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 265  GOODNESS-OF-FIT R-FACTOR AFTER FILTERING ON RG AND RXS-1            
REMARK 265                                                                      
REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 265                                                                      
REMARK 265  OTHER DETAILS: NULL                                                 
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   CA   HIS A   332     CA   ARG A   387              1.19            
REMARK 500   CA   ASP A   329     CA   ASN A   434              1.80            
REMARK 500   CA   PHE A    93     CA   VAL A   143              1.91            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2RLP   RELATED DB: PDB                                   
REMARK 900 FH SCR DOMAINS 1-2 (NMR STRUCTURE)                                   
REMARK 900 RELATED ID: 2RLQ   RELATED DB: PDB                                   
REMARK 900 FH SCR DOMAINS 2-3 (NMR STRUCTURE)                                   
REMARK 900 RELATED ID: 2UWN   RELATED DB: PDB                                   
REMARK 900 FH SCR DOMAINS 6-8 (CRYSTAL STRUCTURE)                               
REMARK 900 RELATED ID: 1HFH   RELATED DB: PDB                                   
REMARK 900 FH SCR DOMAINS 15-16 (NMR STRUCTURE)                                 
REMARK 900 RELATED ID: 2G7I   RELATED DB: PDB                                   
REMARK 900 FH SCR DOMAINS 19-20 (CRYSTAL STRUCTURE)                             
REMARK 900 RELATED ID: 1HAQ   RELATED DB: PDB                                   
REMARK 900 FH SCR 1-20 SOLUTION STRUCTURE FROM 2001                             
REMARK 900 RELATED ID: 2IC4   RELATED DB: PDB                                   
REMARK 900 FH SCR 6-8 SOLUTION STRUCTURE FROM 2007                              
REMARK 900 RELATED ID: 2QFG   RELATED DB: PDB                                   
REMARK 900 FH SCR 1-5 SOLUTION STRUCTURE FROM 2008                              
REMARK 900 RELATED ID: 2QFH   RELATED DB: PDB                                   
REMARK 900 FH SCR 16-20 SOLUTION STRUCTURE FROM 2008                            
REMARK 900 RELATED ID: 3GAU   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 3GAW   RELATED DB: PDB                                   
DBREF  3GAV A   19  1231  UNP    P08603   CFAH_HUMAN      19   1231             
SEQADV 3GAV HIS A  402  UNP  P08603    TYR   402 VARIANT                        
SEQRES   1 A 1213  GLU ASP CYS ASN GLU LEU PRO PRO ARG ARG ASN THR GLU          
SEQRES   2 A 1213  ILE LEU THR GLY SER TRP SER ASP GLN THR TYR PRO GLU          
SEQRES   3 A 1213  GLY THR GLN ALA ILE TYR LYS CYS ARG PRO GLY TYR ARG          
SEQRES   4 A 1213  SER LEU GLY ASN VAL ILE MET VAL CYS ARG LYS GLY GLU          
SEQRES   5 A 1213  TRP VAL ALA LEU ASN PRO LEU ARG LYS CYS GLN LYS ARG          
SEQRES   6 A 1213  PRO CYS GLY HIS PRO GLY ASP THR PRO PHE GLY THR PHE          
SEQRES   7 A 1213  THR LEU THR GLY GLY ASN VAL PHE GLU TYR GLY VAL LYS          
SEQRES   8 A 1213  ALA VAL TYR THR CYS ASN GLU GLY TYR GLN LEU LEU GLY          
SEQRES   9 A 1213  GLU ILE ASN TYR ARG GLU CYS ASP THR ASP GLY TRP THR          
SEQRES  10 A 1213  ASN ASP ILE PRO ILE CYS GLU VAL VAL LYS CYS LEU PRO          
SEQRES  11 A 1213  VAL THR ALA PRO GLU ASN GLY LYS ILE VAL SER SER ALA          
SEQRES  12 A 1213  MET GLU PRO ASP ARG GLU TYR HIS PHE GLY GLN ALA VAL          
SEQRES  13 A 1213  ARG PHE VAL CYS ASN SER GLY TYR LYS ILE GLU GLY ASP          
SEQRES  14 A 1213  GLU GLU MET HIS CYS SER ASP ASP GLY PHE TRP SER LYS          
SEQRES  15 A 1213  GLU LYS PRO LYS CYS VAL GLU ILE SER CYS LYS SER PRO          
SEQRES  16 A 1213  ASP VAL ILE ASN GLY SER PRO ILE SER GLN LYS ILE ILE          
SEQRES  17 A 1213  TYR LYS GLU ASN GLU ARG PHE GLN TYR LYS CYS ASN MET          
SEQRES  18 A 1213  GLY TYR GLU TYR SER GLU ARG GLY ASP ALA VAL CYS THR          
SEQRES  19 A 1213  GLU SER GLY TRP ARG PRO LEU PRO SER CYS GLU GLU LYS          
SEQRES  20 A 1213  SER CYS ASP ASN PRO TYR ILE PRO ASN GLY ASP TYR SER          
SEQRES  21 A 1213  PRO LEU ARG ILE LYS HIS ARG THR GLY ASP GLU ILE THR          
SEQRES  22 A 1213  TYR GLN CYS ARG ASN GLY PHE TYR PRO ALA THR ARG GLY          
SEQRES  23 A 1213  ASN THR ALA LYS CYS THR SER THR GLY TRP ILE PRO ALA          
SEQRES  24 A 1213  PRO ARG CYS THR LEU LYS PRO CYS ASP TYR PRO ASP ILE          
SEQRES  25 A 1213  LYS HIS GLY GLY LEU TYR HIS GLU ASN MET ARG ARG PRO          
SEQRES  26 A 1213  TYR PHE PRO VAL ALA VAL GLY LYS TYR TYR SER TYR TYR          
SEQRES  27 A 1213  CYS ASP GLU HIS PHE GLU THR PRO SER GLY SER TYR TRP          
SEQRES  28 A 1213  ASP HIS ILE HIS CYS THR GLN ASP GLY TRP SER PRO ALA          
SEQRES  29 A 1213  VAL PRO CYS LEU ARG LYS CYS TYR PHE PRO TYR LEU GLU          
SEQRES  30 A 1213  ASN GLY TYR ASN GLN ASN HIS GLY ARG LYS PHE VAL GLN          
SEQRES  31 A 1213  GLY LYS SER ILE ASP VAL ALA CYS HIS PRO GLY TYR ALA          
SEQRES  32 A 1213  LEU PRO LYS ALA GLN THR THR VAL THR CYS MET GLU ASN          
SEQRES  33 A 1213  GLY TRP SER PRO THR PRO ARG CYS ILE ARG VAL LYS THR          
SEQRES  34 A 1213  CYS SER LYS SER SER ILE ASP ILE GLU ASN GLY PHE ILE          
SEQRES  35 A 1213  SER GLU SER GLN TYR THR TYR ALA LEU LYS GLU LYS ALA          
SEQRES  36 A 1213  LYS TYR GLN CYS LYS LEU GLY TYR VAL THR ALA ASP GLY          
SEQRES  37 A 1213  GLU THR SER GLY SER ILE THR CYS GLY LYS ASP GLY TRP          
SEQRES  38 A 1213  SER ALA GLN PRO THR CYS ILE LYS SER CYS ASP ILE PRO          
SEQRES  39 A 1213  VAL PHE MET ASN ALA ARG THR LYS ASN ASP PHE THR TRP          
SEQRES  40 A 1213  PHE LYS LEU ASN ASP THR LEU ASP TYR GLU CYS HIS ASP          
SEQRES  41 A 1213  GLY TYR GLU SER ASN THR GLY SER THR THR GLY SER ILE          
SEQRES  42 A 1213  VAL CYS GLY TYR ASN GLY TRP SER ASP LEU PRO ILE CYS          
SEQRES  43 A 1213  TYR GLU ARG GLU CYS GLU LEU PRO LYS ILE ASP VAL HIS          
SEQRES  44 A 1213  LEU VAL PRO ASP ARG LYS LYS ASP GLN TYR LYS VAL GLY          
SEQRES  45 A 1213  GLU VAL LEU LYS PHE SER CYS LYS PRO GLY PHE THR ILE          
SEQRES  46 A 1213  VAL GLY PRO ASN SER VAL GLN CYS TYR HIS PHE GLY LEU          
SEQRES  47 A 1213  SER PRO ASP LEU PRO ILE CYS LYS GLU GLN VAL GLN SER          
SEQRES  48 A 1213  CYS GLY PRO PRO PRO GLU LEU LEU ASN GLY ASN VAL LYS          
SEQRES  49 A 1213  GLU LYS THR LYS GLU GLU TYR GLY HIS SER GLU VAL VAL          
SEQRES  50 A 1213  GLU TYR TYR CYS ASN PRO ARG PHE LEU MET LYS GLY PRO          
SEQRES  51 A 1213  ASN LYS ILE GLN CYS VAL ASP GLY GLU TRP THR THR LEU          
SEQRES  52 A 1213  PRO VAL CYS ILE VAL GLU GLU SER THR CYS GLY ASP ILE          
SEQRES  53 A 1213  PRO GLU LEU GLU HIS GLY TRP ALA GLN LEU SER SER PRO          
SEQRES  54 A 1213  PRO TYR TYR TYR GLY ASP SER VAL GLU PHE ASN CYS SER          
SEQRES  55 A 1213  GLU SER PHE THR MET ILE GLY HIS ARG SER ILE THR CYS          
SEQRES  56 A 1213  ILE HIS GLY VAL TRP THR GLN LEU PRO GLN CYS VAL ALA          
SEQRES  57 A 1213  ILE ASP LYS LEU LYS LYS CYS LYS SER SER ASN LEU ILE          
SEQRES  58 A 1213  ILE LEU GLU GLU HIS LEU LYS ASN LYS LYS GLU PHE ASP          
SEQRES  59 A 1213  HIS ASN SER ASN ILE ARG TYR ARG CYS ARG GLY LYS GLU          
SEQRES  60 A 1213  GLY TRP ILE HIS THR VAL CYS ILE ASN GLY ARG TRP ASP          
SEQRES  61 A 1213  PRO GLU VAL ASN CYS SER MET ALA GLN ILE GLN LEU CYS          
SEQRES  62 A 1213  PRO PRO PRO PRO GLN ILE PRO ASN SER HIS ASN MET THR          
SEQRES  63 A 1213  THR THR LEU ASN TYR ARG ASP GLY GLU LYS VAL SER VAL          
SEQRES  64 A 1213  LEU CYS GLN GLU ASN TYR LEU ILE GLN GLU GLY GLU GLU          
SEQRES  65 A 1213  ILE THR CYS LYS ASP GLY ARG TRP GLN SER ILE PRO LEU          
SEQRES  66 A 1213  CYS VAL GLU LYS ILE PRO CYS SER GLN PRO PRO GLN ILE          
SEQRES  67 A 1213  GLU HIS GLY THR ILE ASN SER SER ARG SER SER GLN GLU          
SEQRES  68 A 1213  SER TYR ALA HIS GLY THR LYS LEU SER TYR THR CYS GLU          
SEQRES  69 A 1213  GLY GLY PHE ARG ILE SER GLU GLU ASN GLU THR THR CYS          
SEQRES  70 A 1213  TYR MET GLY LYS TRP SER SER PRO PRO GLN CYS GLU GLY          
SEQRES  71 A 1213  LEU PRO CYS LYS SER PRO PRO GLU ILE SER HIS GLY VAL          
SEQRES  72 A 1213  VAL ALA HIS MET SER ASP SER TYR GLN TYR GLY GLU GLU          
SEQRES  73 A 1213  VAL THR TYR LYS CYS PHE GLU GLY PHE GLY ILE ASP GLY          
SEQRES  74 A 1213  PRO ALA ILE ALA LYS CYS LEU GLY GLU LYS TRP SER HIS          
SEQRES  75 A 1213  PRO PRO SER CYS ILE LYS THR ASP CYS LEU SER LEU PRO          
SEQRES  76 A 1213  SER PHE GLU ASN ALA ILE PRO MET GLY GLU LYS LYS ASP          
SEQRES  77 A 1213  VAL TYR LYS ALA GLY GLU GLN VAL THR TYR THR CYS ALA          
SEQRES  78 A 1213  THR TYR TYR LYS MET ASP GLY ALA SER ASN VAL THR CYS          
SEQRES  79 A 1213  ILE ASN SER ARG TRP THR GLY ARG PRO THR CYS ARG ASP          
SEQRES  80 A 1213  THR SER CYS VAL ASN PRO PRO THR VAL GLN ASN ALA TYR          
SEQRES  81 A 1213  ILE VAL SER ARG GLN MET SER LYS TYR PRO SER GLY GLU          
SEQRES  82 A 1213  ARG VAL ARG TYR GLN CYS ARG SER PRO TYR GLU MET PHE          
SEQRES  83 A 1213  GLY ASP GLU GLU VAL MET CYS LEU ASN GLY ASN TRP THR          
SEQRES  84 A 1213  GLU PRO PRO GLN CYS LYS ASP SER THR GLY LYS CYS GLY          
SEQRES  85 A 1213  PRO PRO PRO PRO ILE ASP ASN GLY ASP ILE THR SER PHE          
SEQRES  86 A 1213  PRO LEU SER VAL TYR ALA PRO ALA SER SER VAL GLU TYR          
SEQRES  87 A 1213  GLN CYS GLN ASN LEU TYR GLN LEU GLU GLY ASN LYS ARG          
SEQRES  88 A 1213  ILE THR CYS ARG ASN GLY GLN TRP SER GLU PRO PRO LYS          
SEQRES  89 A 1213  CYS LEU HIS PRO CYS VAL ILE SER ARG GLU ILE MET GLU          
SEQRES  90 A 1213  ASN TYR ASN ILE ALA LEU ARG TRP THR ALA LYS GLN LYS          
SEQRES  91 A 1213  LEU TYR SER ARG THR GLY GLU SER VAL GLU PHE VAL CYS          
SEQRES  92 A 1213  LYS ARG GLY TYR ARG LEU SER SER ARG SER HIS THR LEU          
SEQRES  93 A 1213  ARG THR THR CYS TRP ASP GLY LYS LEU GLU TYR PRO THR          
SEQRES  94 A 1213  CYS ALA LYS ARG                                              
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1                                                                  
(ATOM LINES ARE NOT SHOWN.)
END                                                                             
DBGET integrated database retrieval system